The market in Spain recorded a revenue of USD 11.87 billion in 2025.
By the end of the 2033, the Spain Infusion Services Market is projected to reach USD 30.07 billion, supported by a CAGR of 12.3% during the projection horizon.
Regional oncology program expansion is steadily increasing systemic therapy administration across public hospitals, strengthening infusion throughput particularly in Madrid and Catalonia where tertiary care density is highest.
The Spanish Society of Medical Oncology reports continued growth in active cancer cases requiring systemic treatment, reinforcing sustained biologic infusion demand within the national health system.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]